<b>Background</b>: Although the BRAF gene mutation in colorectal cancer has a prognostic value and a therapeutic interest, very few studies address the prevalence of this mutation in the Middle East, and hardly any among the Lebanese population. The gene discussed is BRAF; the disease is colorectal cancer.